Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

How does the estrogen receptor work?

Jennifer M Gross1, Douglas Yee

  • 1University of Minnesota Cancer Center, Department of Pharmacology, Minneapolis 55455, USA.

Breast Cancer Research : BCR
|March 7, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tumor-specific lncRNA IGF1R-AS1 trans-regulates chromatin interactions associated with oncogenic MYC signaling.

Nature communications·2026
Same author

Identification of Early Symptoms Associated with Subsequent Immune-related Adverse Events in the I-SPY clinical trial.

Research square·2026
Same author

RISE UP for breast cancer 2024: conference highlights & takeaways.

Breast cancer research and treatment·2026
Same author

mRNA and Protein Expression of Fetal Insulin Receptor in Breast Cancer Cell Lines.

bioRxiv : the preprint server for biology·2025
Same author

Enhancing Clinical Cancer Research Through Sharing of Data and Biospecimens.

JAMA oncology·2025
Same author

Immune and Growth Factor Signaling Pathways Are Associated with Pathologic Complete Response to an Anti-Type I Insulin-like Growth Factor Receptor Regimen in Patients with Breast Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same journal

Longitudinal evaluation of tumor-infiltrating lymphocyte scoring using automated region of interest registration in breast cancer.

Breast cancer research : BCR·2026
Same journal

Exploring LTB-mediated T cell differentiation as a prognostic marker in triple-negative breast cancer.

Breast cancer research : BCR·2026
Same journal

Intraoperative NIR-II fluorescence guidance for precise tumor margin assessment and maximized tissue preservation in breast surgery.

Breast cancer research : BCR·2026
Same journal

Tumour-based DNA methylation markers of breast cancer survival: a pooled analysis of 2157 cases.

Breast cancer research : BCR·2026
Same journal

Comprehensive comparison of homologous recombination deficiency predictors in early-stage triple-negative breast cancer.

Breast cancer research : BCR·2026
Same journal

Breastfeeding shapes a unique tumor-immune landscape in pregnancy-associated breast cancer from GEICAM-EMBARCAM study.

Breast cancer research : BCR·2026
See all related articles

Estrogen receptor-alpha (ER-alpha) drives breast cancer growth by regulating insulin-like growth factor signaling. Unliganded ER-alpha may also stimulate cancer cell proliferation, offering new therapeutic targets.

Area of Science:

  • Oncology
  • Endocrinology
  • Molecular Biology

Background:

  • Estrogen receptor-alpha (ER-alpha) is a key target in breast cancer therapy.
  • The exact role of ER-alpha in breast tumor biology remains incompletely understood.
  • Understanding ER-alpha's function is crucial for developing effective breast cancer treatments.

Purpose of the Study:

  • To investigate the biological actions of ER-alpha in breast cancer.
  • To elucidate the mechanism by which ER-alpha promotes breast cancer cell growth.
  • To explore the potential role of unliganded ER-alpha in breast cancer proliferation.

Main Methods:

  • The study analyzed the impact of ER-alpha on signaling components of the insulin-like growth factor system.
  • Gene expression patterns related to ER-alpha activity were examined.

Related Experiment Videos

  • Potential mechanisms for ER-alpha-mediated breast cancer cell stimulation were proposed.

    • Main Results:

    • ER-alpha was found to promote breast cancer cell growth by targeting the insulin-like growth factor system.
    • Evidence suggests ER-alpha influences the expression of critical signaling molecules.
    • A potential mechanism for ER-alpha to stimulate proliferation, even in its unliganded state, was identified.

    Conclusions:

    • ER-alpha plays a significant role in promoting breast cancer growth, partly through the insulin-like growth factor pathway.
    • Unliganded ER-alpha may also contribute to breast cancer proliferation, suggesting broader therapeutic implications.
    • Further research into ER-alpha's multifaceted actions could lead to novel breast cancer therapies.